Rule2021-13212
Health and Safety Data Reporting; Addition of 20 High-Priority Substances and 30 Organohalogen Flame Retardants
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 29, 2021
Effective
July 29, 2021
Issuing agencies
Environmental Protection Agency
Abstract
This final rule, issued pursuant to the Toxic Substances Control Act (TSCA) and the TSCA Health and Safety Data Reporting rule, requires manufacturers (including importers) of 50 specified chemical substances to report certain lists and copies of unpublished health and safety studies to EPA. The chemical substances subject to this rule are listed in this document and consist of the 20 designated by EPA as High-Priority Substances and the 30 organohalogen flame retardants being evaluated for risks by the Consumer Product Safety Commission (CPSC) under the Federal Hazardous Substances Act (FHSA). EPA is taking this action because the TSCA Interagency Testing Committee (ITC) added these chemical substances to the Priority Testing List through its 69th and 74th Reports and EPA will use this information to inform the risk evaluations currently underway for 20 High-Priority Substances and for future prioritization.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 122 (Tuesday, June 29, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 122 (Tuesday, June 29, 2021)]
[Rules and Regulations]
[Pages 34147-34154]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-13212]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 716
[EPA-HQ-OPPT-2020-0474; FRL-10020-38]
RIN 2070-AB11
Health and Safety Data Reporting; Addition of 20 High-Priority
Substances and 30 Organohalogen Flame Retardants
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This final rule, issued pursuant to the Toxic Substances
Control Act (TSCA) and the TSCA Health and Safety Data Reporting rule,
requires manufacturers (including importers) of 50 specified chemical
substances to report certain lists and copies of unpublished health and
safety studies to EPA. The chemical substances subject to this rule are
listed in this document and consist of the 20 designated by EPA as
High-Priority Substances and the 30 organohalogen flame retardants
being evaluated for risks by the Consumer Product Safety Commission
(CPSC) under the Federal Hazardous Substances Act (FHSA). EPA is taking
this action because the TSCA Interagency Testing Committee (ITC) added
these chemical substances to the Priority Testing List through its 69th
and 74th Reports and EPA will use this information to inform the risk
evaluations currently underway for 20 High-Priority Substances and for
future prioritization.
DATES: This final rule is effective July 29, 2021. For purposes of
judicial review, this final rule shall be promulgated at 1 p.m. eastern
daylight/standard time July 13, 2021
A request to withdraw a chemical substance from this final rule
pursuant to 40 CFR 716.105(c) must be received on or before July 13,
2021. (See Unit IV. of the SUPPLEMENTARY INFORMATION.)
Dates for the reporting requirements are enumerated in Unit III.B.
of the SUPPLEMENTARY INFORMATION.
ADDRESSES:
Comments. Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPPT-2020-0474, by using the Federal eRulemaking
Portal at <a href="http://www.regulations.gov">http://www.regulations.gov</a>. Follow the online instructions
for submitting comments. Do not submit electronically any information
you consider to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is closed to visitors with
limited exceptions. The staff continues to provide remote customer
service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit <a href="https://www.epa.gov/dockets">https://www.epa.gov/dockets</a>.
Withdrawal requests. For submission of a withdrawal request, see
Unit IV. of this document. Each withdrawal request must be identified
by docket ID number EPA-HQ-OPPT-2020-0474.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Diana Fahning, Data Gathering
and Analysis Division (7410M), Office of Pollution Prevention and
Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460-0001; telephone number: (202) 564-8621; email
address: <a href="/cdn-cgi/l/email-protection#0b6d6a636562656c256f626a656a4b6e7b6a256c647d"><span class="__cf_email__" data-cfemail="5533343d3b3c3b327b313c343b34153025347b323a23">[email protected]</span></a>.
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: <a href="/cdn-cgi/l/email-protection#57030414167a1f38233b3e39321732273679303821"><span class="__cf_email__" data-cfemail="0551564644284d6a71696c6b60456075642b626a73">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
[[Page 34148]]
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you manufacture
(defined by statute to include import) any of the chemical substances
that are listed in 40 CFR 716.120(d) of the regulatory text of this
document. The following list of North American Industrial
Classification System (NAICS) codes is not intended to be exhaustive,
but rather provides a guide to help readers determine whether this
document applies to them. Potentially affected entities may include:
Chemical manufacturers (including importers), (NAICS codes 325 and
324110), e.g., persons who manufacture (defined by statute to include
import) one or more of the subject chemical substances.
B. What should I consider as I prepare my comments for EPA?
1. Submitting CBI. Do not submit this information to EPA through
<a href="http://www.regulations.gov">http://www.regulations.gov</a> or email. Clearly mark the part or all of
the information that you claim to be CBI. For CBI information in a disk
or CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM
as CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
2. Tips for preparing your comments. When preparing and submitting
your comments, see the commenting tips at <a href="https://www.epa.gov/dockets/commenting-epa-dockets">https://www.epa.gov/dockets/commenting-epa-dockets</a>.
II. Background
A. What action is the Agency taking?
EPA is issuing a final rule pursuant to TSCA section 8(d) to
require manufacturers (including importers) of chemical substances
listed in this document and on the ITC's TSCA section 4(e) Priority
Testing List to submit lists and copies of certain unpublished health
and safety studies to EPA. The regulatory text of this document lists
the chemical substances and their Chemical Abstracts Service Registry
Numbers (CASRN) that are being added to the Health and Safety Data
Reporting rule. It also lists the specific data reporting requirements
imposed by this final rule.
B. What is the Agency's authority for taking this action?
EPA promulgated the Health and Safety Data Reporting rule under
TSCA section 8(d) (15 U.S.C. 2607(d)), and it is codified at 40 CFR
part 716. EPA is using this TSCA section 8(d) rule in accordance with
40 CFR 716.105 to gather information on chemical substances. These
studies are expected to provide EPA with useful information for
conducting TSCA activities such as prioritization and risk evaluation.
The Agency adds substances to the rule via rule or notice, in
accordance with 40 CFR 716.105(a) or (b), respectively. The rule
requires certain past, current, and prospective manufacturers (which
under TSCA includes importers) to submit copies and/or lists of
unpublished health and safety studies on the listed chemical substances
that they manufacture. In some cases, EPA may also require processors
to comply with the rule.
The TSCA section 8(d) Health and Safety Data Reporting rule
provides for the addition of TSCA section 4(e) Priority Testing List
chemical substances to the list of chemical substances subject to the
rule (see Table of Chemicals, 40 CFR 716.120) (Ref. 1). Whenever EPA
announces the receipt of an ITC Report, EPA may, amend the TSCA section
8(d) Health and Safety Data Reporting rule by adding the recommended
(or designated) chemical substances to the TSCA section 4(e) list. In
doing so, EPA must provide a 14-day period (measured from the date of
publication of the Federal Register document announcing the rule) for
persons to submit information showing why a chemical substance,
mixture, or category of chemical substances should be withdrawn from
the amendment. The amendment adding these chemical substances to the
Health and Safety Data Reporting rule is effective July 29, 2021. If
EPA withdraws a chemical substance from the amendment, a Federal
Register document announcing this decision is to be published no later
than July 29, 2021.
C. Comments Received on the 74th Report of the ITC
EPA received seven public comments on the 74th Report of the ITC.
One comment requested additional information be provided for why
certain organohalogen flame retardants being added to the Priority
Testing List (PTL). Several comments questioned whether requiring 8(d)
reporting for a chemical substance for which EPA has issued a Section 4
Test Order would be redundant and/or produce data in time for use in a
risk evaluation under TSCA section 6 on the applicable chemical
substance. EPA also received a comment on chemicals substances to
remove from the PTL. Additionally, one commenter recommended additional
activities for EPA to conduct related to fulfilling data needs (e.g.,
via the use of Test Orders pursuant to section 4 of TSCA).
EPA has reviewed the comments and continues to believe that it is
appropriate to list these chemical substances in this document onto the
ITC's TSCA section 4(e) Priority Testing List to prompt EPA to
implement their authority pursuant to TSCA section 8(d), to require
manufacturers (including importers) to submit lists and copies of
certain unpublished health and safety studies to EPA. The 74th ITC
Report provided the basis for its inclusion of all chemical substances
that were added to the PTL. Regarding possible redundancies of
published and previously submitted information under other TSCA
programs, under 40 CFR 716.20(a) certain studies are exempt from the
copy and list submission requirements of 40 CFR 716.30 and 716.35.
Within EPA's current timeline for risk evaluations under TSCA section
6, data received via this 8(d) action would be received in time for use
in risk evaluations for chemical substances that have been designated
as high-priority substances, and data received on the other chemical
substances listed in this document would help inform future
prioritization activities, as well as help inform other agency
decisions involving such chemical substances. In regard to chemical
substances being recommended for deletion from the PTL and for requests
for certain activities to be undertaken in regard to certain chemical
substances, EPA will consider such recommendations during future ITC
discussions and during decision-making related to its various TSCA
statutory authorities.
D. Why is this action issued as a Final Rule?
The regulations at 40 CFR 716.105(b) and (c) establish the process
for this action to amend the TSCA section 8(d) Health and Safety Data
Reporting rule.
III. Final Rule
A. What chemical substances are added?
In this document, EPA is adding chemical substances to the TSCA
section 8(d) Health and Safety Data Reporting rule. This addition
implements 40 CFR 716.105(b), which generally provides that ``chemical
substances, mixtures, and categories of
[[Page 34149]]
chemical substances that have been added to the TSCA section 4(e)
Priority List by the Interagency Testing Committee, established under
section 4 of TSCA, will be added to Sec. 716.120 . . .'' This addition
also addresses the request of the TSCA ITC in its 74th Report (Ref. 2)
to add certain chemical substances listed in that report to the TSCA
section 8(d) Health and Safety Data Reporting rule. The specific
chemical substances being added to the rule are listed in the
regulatory text at the end of this document.
B. What are the reporting requirements?
Listed in this unit are the reporting requirements for the chemical
substances added by this final rule to the TSCA section 8(d) model
Health and Safety Data Reporting rule. The specific types of health and
safety studies that must be reported for each of the chemical
substances added to the Health and Safety Data Reporting rule as a
result of this document can be found in Unit III.C.
1. Persons who, in the 10 years preceding the date a chemical
substance is listed, either have proposed to manufacture (including
import) or have manufactured (including imported) the listed chemical
substance must submit to EPA, during the 60-day reporting period
specified in 40 CFR 716.65 and according to the reporting schedule set
forth at 40 CFR 716.60, a copy of each specified type of health and
safety study which is in their possession at the time the chemical
substance is listed in part 716.
2. Persons who, at the time the chemical substance is listed in
part 716, propose to manufacture (including import) or are
manufacturing (including importing) the listed chemical substance must
submit to EPA during the 60-day reporting period specified in 40 CFR
716.65 and according to the reporting schedule set forth at 40 CFR
716.60:
i. A list of the specified types of health and safety studies known
to them but not in their possession at the time the chemical substance
is listed.
ii. A list of the specified types of health and safety studies that
are ongoing at the time the chemical substance is listed and are being
conducted by or for them.
iii. A list of the specified types of health and safety studies
that are initiated after the date the chemical substance is listed and
will be conducted by or for them.
iv. A copy of each specified type of health and safety study which
is in their possession at the time the chemical substance is listed.
v. A copy of each specified type of health and safety study that
was previously listed as ongoing or subsequently initiated (i.e.,
listed in accordance with reporting requirements in Unit III.B.2.iii.
and iv., respectively) and is now complete--regardless of completion
date.
3. Persons who, after the time the chemical substance is listed in
part 716, propose to manufacture (including import) the listed chemical
substance must submit to EPA during the reporting period specified in
40 CFR 716.65 and according to the reporting schedule set forth at 40
CFR 716.60:
i. A list of the specified types of health and safety studies known
to them but not in their possession at the time they propose to
manufacture (including import) the listed chemical substance.
ii. A list of the specified types of health and safety studies that
are ongoing at the time they propose to manufacture (including import)
the listed chemical substance and are being conducted by or for them.
iii. A list of the specified types of health and safety studies
that are initiated after the time they propose to manufacture
(including import) the listed chemical substance and will be conducted
by or for them.
iv. A copy of each specified type of health and safety study which
is in their possession at the time they propose to manufacture
(including import) the listed chemical substance.
v. A copy of each specified type of health and safety study that
was previously listed as ongoing or subsequently initiated (i.e.,
listed in accordance with reporting requirements in Unit III.B.3.iii.
and 3.iv., respectively) and is now complete--regardless of the
completion date.
The reporting described in Unit III.B. is required by September 27,
2021. Any person who manufactures (including imports) or who proposes
to manufacture (including import) the listed chemical substance from
July 29, 2021 to September 27, 2021 must inform EPA (by submitting a
list) of any studies initiated during the period from July 29, 2021 to
September 27, 2021 within 30 days of their initiation, but in no case
later than October 27, 2021. In addition, if any such person has
submitted lists of studies that were ongoing or initiated during the
period from July 29, 2021 to September 27, 2021 to EPA, such person
must submit a copy of each study within 30 days after its completion,
regardless of the study's completion date. See 40 CFR 716.60 and
716.65.
Detailed guidance for reporting unpublished health and safety data
and explanations of reporting exemptions is provided at 40 CFR part
716.
Persons reporting under this rule may also assert CBI claims for
certain information included in their submission. TSCA section imposes
the following requirements:
<bullet> CBI claims must be asserted must be asserted at the time
the information claimed as CBI is submitted to EPA. Information
submitted with a confidentiality claim may be made public without
further notice.
<bullet> Information claimed as CBI must be substantiated at the
time of submission, with the exception of those types of information
exempt from substantiation under TSCA section 14(c)(2).
<bullet> All persons making a CBI claim must provide a standard
statement concerning the need for the CBI claim and a certification
that the statement of need is true and correct.
<bullet> Where a specific chemical identity is claimed as CBI, a
structurally descriptive generic name must be provided for disclosure
to the public.
The 8(d) reporting application accommodates these requirements,
incorporating the required statements and certifications, and will
prompt the submitter to provide substantiation prior to making a
submission that includes CBI claims.
C. What types of studies must be submitted?
Pursuant to 40 CFR 716.20(b)(5) and 716.50, the types of
unpublished health and safety studies that must be reported and the
chemical grade/purity requirements that must be met or exceeded in
individual studies for the chemical substances added to the Health and
Safety Data Reporting rule as a result of this document are as follows:
Under this rule, manufacturers (including importers) of High-
Priority Substances are required to submit the following:
<bullet> Lists and copies of unpublished health and safety studies
for all High-Priority Substances specified in this rule on health
effects, such as toxicity studies (in vivo and in vitro) on
carcinogenicity, reproductive and developmental effects, genotoxicity,
neurotoxicity, immunotoxicity, endocrine effects, and other systemic
toxicity and toxicokinetics (absorption, distribution, metabolism, or
elimination), including modelling studies, in humans or animals.
<bullet> All unpublished studies on environmental effects,
environmental fate, and physical-chemical properties if performed as
described in 40 CFR 716.50 are also required under this rule.
[[Page 34150]]
<bullet> All unpublished studies on occupational (both users and
non-users), general population, consumer, and environmental exposure,
such as: Unpublished studies on inhalation and dermal exposure, human
biomonitoring, environmental monitoring of indoor and outdoor air,
soil, water, and household dust, chamber emission rates from products
or polymeric matrices, and unpublished modelling studies that estimate
environmental concentrations or human exposures.
<bullet> Studies showing any measurable content of the High-
Priority Substance in the tested substance (single substances or
mixture) must be reported. The composition and purity of test
substances must be reported if included as part of the study.
<bullet> Studies previously submitted to EPA pursuant to a
requirement under TSCA or of the submitter's own accord and studies
conducted or to be conducted pursuant to a TSCA section 4 action are
exempt from the submission of lists of health and safety studies
required under 40 CFR 716.35 and the submission of studies required
under this rule.
Under this rule, manufacturers (including importers) of
organohalogen flame retardants are required to submit the following:
<bullet> Lists and copies of unpublished health and safety studies
for all organohalogen flame retardants specified in this rule on health
effects, such as toxicity studies (in vivo and in vitro) on
carcinogenicity, reproductive and developmental effects, genotoxicity,
neurotoxicity, immunotoxicity, endocrine effects, and other systemic
toxicity and toxicokinetics (absorption, distribution, metabolism, or
elimination), including modelling studies, in humans or animals.
<bullet> All unpublished studies on environmental effects,
environmental fate, and physical-chemical properties if performed as
described in 40 CFR 716.50 are also required under this rule.
<bullet> All unpublished studies on occupational (both users and
non-users), general population, consumer, and environmental exposure,
such as unpublished studies on inhalation and dermal exposure, human
biomonitoring, environmental monitoring of indoor and outdoor air,
soil, water, and household dust, chamber emission rates from products
or polymeric matrices, and unpublished modelling studies that estimate
environmental concentrations or human exposures, must be submitted.
<bullet> Studies showing any measurable content of the
organohalogen flame retardant in the tested substance (single
substances or mixture) must be reported. The composition and purity of
test substances must be reported if included as part of the study.
<bullet> Studies previously submitted to EPA pursuant to a
requirement under TSCA or of the submitter's own accord and studies
conducted or to be conducted pursuant to a TSCA section 4 action are
exempt from the submission of lists of health and safety studies
requirements under 40 CFR 716.35 and the submission of studies
requirements under this rule.
D. Rationales and Background for Chemical Additions and Reporting
Requirements
1. High-Priority Substances
The 20 High-Priority Substances identified in this rule have been
designated High-Priority under TSCA section 6(b) because EPA has found
that each of these chemical substances may present an unreasonable risk
of injury to health or the environment (Ref. 3). EPA is seeking
unpublished health and safety studies to ensure that such studies are
available to EPA to inform its risk evaluation findings of whether any
of these High-Priority Substances present an unreasonable risk of
injury to health or the environment. Further, this information will be
considered, as appropriate, when reviewing potential analogue data for
read across and/or category development in assessing new chemicals.
2. Organohalogen Flame Retardants
EPA requests this information to help support prioritization and
evaluation activities under TSCA (see TSCA section 6(b), and as
discussed above). Further, this information will be considered, as
appropriate, when reviewing potential analogue data for read across
and/or category development in assessing new chemicals. Additionally,
CPSC, a representative member of the ITC, needs information on a group
of organohalogen flame retardants because the Commission voted to grant
a petition to begin rulemaking for this class of chemicals under the
Federal Hazardous Substances Act (FHSA), (Ref. 5). Organohalogen flame
retardants may be added to consumer products to prevent or slow
combustion, but are additive, i.e., not covalently bound to the
substrate, which can be textiles, polymers, or foam. Most organohalogen
flame retardants are semi-volatile compounds (SVOCs), that can migrate
into air, where they bind to airborne particles and surfaces in the
home. In addition to direct contact with organohalogen flame retardant-
containing products, a substantial portion of exposure is believed to
occur from exposure to household dust, especially in children.
Biomonitoring studies and measurements of household dust and indoor air
demonstrate that exposure to organohalogen flame retardants is nearly
ubiquitous.
Many organohalogen flame retardants have been shown to cause health
effects. Health effects associated with organohalogen flame retardants
include carcinogenicity (e.g., halogenated alkyl phosphates),
developmental effects (e.g., polybrominated diphenyl ethers (PBDEs)),
and developmental neurotoxicity (e.g., Decabromodiphenyl ether
(decaBDE)).
In 2015, CPSC was petitioned by a number of organizations and
individuals, such as consumer groups, medical associations, workers,
and firefighter organizations, to ban the use of all additive, non-
polymeric organohalogen flame retardants under the authority of the
FHSA in the following consumer products: (1) Durable infant or toddler
products, children's toys, child care articles, or other children's
products (other than car seats, which are under Department of
Transportation's jurisdiction); (2) Residential upholstered furniture;
(3) Mattresses and mattress pads; and (4) The plastic casings of
electronic devices (Ref. 5).
CPSC granted the petition in 2017 and directed staff to complete a
scoping and feasibility study in cooperation with the National Academy
of Sciences, Engineering, and Medicine (NASEM). The task for this
project was to develop a scientifically based scoping plan to identify
the potential health hazards associated with additive, nonpolymeric
organohalogen flame retardants as a class. The NASEM Committee
published the report, ``A Class Approach to Hazard Assessment of
Organohalogen Flame Retardants'' in May 2019 (Ref. 6). A key conclusion
of the NASEM Committee is that organohalogen flame retardants cannot be
treated as a single class. Rather, the NASEM Committee identified 14
subclasses of organohalogen flame retardants, based on chemical
structure, physicochemical properties of the chemicals, and predicted
biologic activity. The NASEM Committee identified 161 organohalogen
flame retardants and more than 1,000 analog chemicals. CPSC staff is
undertaking the risk assessment of 14 classes of organohalogen flame
retardants following the recommendations of the NASEM Committee.
Because preliminary searches show that little or no health and
safety
[[Page 34151]]
information is available for many of the 161 organohalogen flame
retardants, including the organohalogen flame retardants being added
here to the TSCA section 8(d) Health and Safety Data Reporting rule,
the submission of the lists and copies of the unpublished health and
safety studies specified in this rule is being required under the TSCA
section 8(d) Health and Safety Data Reporting rule for these OFR
additions. As indicated above, this information will also inform TSCA
activities such as future prioritization efforts and, with potential
read-across data, new chemical reviews. Further, EPA will coordinate
with ITC members to share information received, as appropriate (e.g.,
to help inform CPSC's evaluation of specific chemicals).
E. What are the incremental economic implications of this action?
EPA prepared an economic analysis for the addition of the 50
chemical substances to the TSCA section 8(d) Health and Safety Data
Reporting rule, entitled, ``TSCA Section 8(d): Economic Impact Analysis
for Adding 50 Chemicals from the 74th ITC Report of the TSCA
Interagency Testing Committee to the Health and Safety Data Reporting
Rule.'' (Economic Analysis, Ref. 7) a copy of which is included in the
docket for this rulemaking. The total one-time cost associated with
this final rule is estimated to be approximately $185,000 based on
approximately 1,900 and 420 hours of industry and EPA burden,
respectively.
IV. Requesting a Chemical Substance Be Withdrawn From This Final Rule
As specified in 40 CFR 716.105(c), EPA may, in its discretion,
remove a chemical substance, mixture, or category of chemical
substances from this final rule for good cause prior to the effective
date of this final rule. Any person who believes that the reporting
required by this final rule is not warranted for a chemical substance
listed in this final rule must submit to EPA detailed reasons for that
belief. You must submit your request to EPA on or before July 13, 2021
and in accordance with the instructions provided in 40 CFR 716.105(c)
and (d). In addition, to ensure proper receipt by EPA, you must
identify docket ID number EPA-HQ-OPPT-2020-0474. If the EPA
Administrator withdraws a chemical substance, mixture, or category of
chemical substances from the amendment, in accordance with 40 CFR
716.105(c), a Federal Register document announcing this decision will
be published no later than July 29, 2021.
V. References
The following is a listing of the documents that are specifically
referenced in this document. The docket includes these documents and
other information considered by EPA. For more information about these
references, please consult the technical person listed under FOR
FURTHER INFORMATION CONTACT.
1. EPA. 40 CFR 716.120. Substances and listed mixtures to which this
subpart applies. Available online at: <a href="https://www.ecfr.gov/cgibin/textidx?SID=94b50835053a07b80c3517fff641aeba&mc=true&node=pt40.33.716&rgn=div5#se40.33.716_1120">https://www.ecfr.gov/cgibin/textidx?SID=94b50835053a07b80c3517fff641aeba&mc=true&node=pt40.33.716&rgn=div5#se40.33.716_1120</a>.
2. ITC. Notice; Seventy-Fourth Report of the TSCA Interagency
Testing Committee to the Administrator of the Environmental
Protection Agency; Receipt of Report and Request for Comments.
Federal Register (86 FR 22414, April 28, 2021) (FRL-10020-39).
Available online at: <a href="https://www.govinfo.gov/content/pkg/FR-2021-04-28/pdf/2021-08839.pdf">https://www.govinfo.gov/content/pkg/FR-2021-04-28/pdf/2021-08839.pdf</a>.
3. EPA. High-Priority Substance Designations Under the Toxic
Substances Control Act (TSCA) and Initiation of Risk Evaluation on
High-Priority Substances; Notice of Availability. Federal Register
(84 FR 71924, December 30, 2019) (FRL-10003-15). Available online
at: <a href="https://www.govinfo.gov/content/pkg/FR-2019-12-30/pdf/2019-28225.pdf">https://www.govinfo.gov/content/pkg/FR-2019-12-30/pdf/2019-28225.pdf</a>.
4. EPA. Procedures for Prioritization of Chemicals for Risk
Evaluation Under the Toxic Substances Control Act; Final Rule.
Federal Register (82 FR 33753, December 20, 2017) (FRL-9964-24).
Available online at: <a href="https://www.federalregister.gov/documents/2017/07/20/2017-14325/procedures-for-prioritization-of-chemicals-for-risk-evaluation-under-the-toxic-substances-control">https://www.federalregister.gov/documents/2017/07/20/2017-14325/procedures-for-prioritization-of-chemicals-for-risk-evaluation-under-the-toxic-substances-control</a>.
5. CPSC. U.S. Consumer Product Safety Commission Petition: Products
Containing Organohalogen Flame Retardants. Docket ID number: CPSC-
2015-0022. Available online at: <a href="https://www.regulations.gov/docket?D=CPSC-2015-0022">https://www.regulations.gov/docket?D=CPSC-2015-0022</a>.
6. CPSC. National Academies of Sciences, Engineering, and Medicine
2019. A Class Approach to Hazard Assessment of Organohalogen Flame
Retardants. Washington, DC: The National Academies Press. <a href="https://doi.org/10.17226/25412">https://doi.org/10.17226/25412</a>. Available online at: <a href="http://nap.edu/25412">http://nap.edu/25412</a>.
7. EPA. TSCA Section 8(d): Economic Impact Analysis for Adding 50
Chemicals From the 74th ITC Report of the TSCA Interagency Testing
Committee to the Health and Safety Data Reporting Rule. September
10, 2020.
VI. Statutory and Executive Order Reviews
Additional information about these statutes and Executive Orders
can be found at <a href="http://www2.epa.gov/laws-regulations/laws-and-executive-orders">http://www2.epa.gov/laws-regulations/laws-and-executive-orders</a>.
A. Executive Order 12866: Regulatory Planning and Review and Executive
Order 13563: Improving Regulation and Regulatory Review
The Office of Management and Budget (OMB) has exempted actions
under TSCA section 8(d) related to the Health and Safety Data Reporting
rule from the requirements of Executive Order 12866 (58 FR 51735,
October 4, 1993). As such, this final rule was not reviewed by OMB
under Executive Orders 12866 and 13563 (76 FR 3821, January 21, 2011).
B. Paperwork Reduction Act (PRA)
According to PRA, 44 U.S.C. 3501 et seq., an agency may not conduct
or sponsor, and a person is not required to respond to a collection of
information that requires OMB approval under PRA, unless it has been
approved by OMB and displays a currently valid OMB control number. The
OMB control numbers for EPA's regulations in title 40 of the CFR, after
appearing in the Federal Register, are listed in 40 CFR part 9, and
included on the related collection instrument or form, if applicable.
The information collection requirements related to this action have
already been approved by OMB pursuant to PRA under OMB control number
2070-0004. This action does not impose any burden requiring additional
OMB approval. You can find a copy of the ICR in the docket for this
rule, and it is briefly summarized here.
This action requires the reporting of health and safety data to EPA
by manufacturers (including importers) of certain chemical substances
requested by the ITC to be added to the Health and Safety Data
Reporting Rule in its Seventy-Fourth Report of the ITC (Ref. 2). EPA
intends to use information collected under the rule to assist in
chemical assessments under TSCA, and to inform any additional work
necessary under environmental protection mandates beyond TSCA.
Submitters may designate information as confidential, trade secret, or
proprietary. EPA has implemented procedures to protect any
confidential, trade secret or proprietary information from disclosure.
These procedures comply with TSCA section 14 and EPA's confidentiality
regulation, 40 CFR part 2, subpart B.
Respondents/affected entities: Manufacturers (including importers)
of 50 chemical substances requested by the ITC to be included in the
Health and Safety Data Reporting Rule.
Respondents' obligation to respond: Mandatory (15 U.S.C. 2607(d)).
Estimated number of respondents: 23.
Frequency of response: Once.
[[Page 34152]]
Total estimated burden: 1,854 hours (per year). Burden is defined
at 5 CFR 1320.3(b).
Total estimated cost: $146,745 (per year), with no annualized
capital or operation and maintenance costs.
C. Regulatory Flexibility Act (RFA)
Pursuant to RFA section 605(b), 5 U.S.C. 601 et seq., I hereby
certify that this action will not have a significant economic impact on
a substantial number of small entities as defined by the RFA. The small
entities subject to the requirements of this action are manufacturers
(including importers) of 50 chemicals requested by the ITC to be added
to the Health and Safety Data Reporting Rule. EPA estimates that 106 of
the 129 firms in the affected universe are small entities. Of those
small firms, all would have cost impacts of less than 1% of annual
revenue. Details of this analysis are presented in the Economic
Analysis of this rule (Ref. 7), which can be found in the docket.
D. Unfunded Mandates Reform Act (UMRA)
This action does not contain an unfunded mandate of $100 million or
more as described in UMRA, 2 U.S.C. 1531-1538, and does not
significantly or uniquely affect small governments. The requirements of
this action would primarily affect manufacturers (including importers)
of 50 chemical substances listed in 40 CFR 716.120(d) of the regulatory
text of this document. The total quantified one-time costs of this
final rule are approximately $183,812.
E. Executive Order 13132: Federalism
This action does not have federalism implications as specified in
Executive Order 13132 (64 FR 43255, August 10, 1999). It will not have
substantial direct effects on the states, on the relationship between
the national government and the states, or on the distribution of power
and responsibilities among the various levels of government.
F. Executive Order 13175: Consultation and Coordination With Indian
Tribal Governments
This action does not have tribal implications as specified in
Executive Order 13175 (65 FR 67249, November 9, 2000). It will not have
substantial direct effects on tribal governments, on the relationship
between the Federal government and the Indian tribes, or on the
distribution of power and responsibilities between the Federal
government and Indian tribes. Thus, E.O. 13175 does not apply to this
action.
G. Executive Order 13045: Protection of Children From Environmental
Health Risks and Safety Risks
EPA interprets Executive Order 13045 (62 FR 19885, April 23, 1997)
as applying only to those regulatory actions that concern environmental
health or safety risks that the Agency has reason to believe may
disproportionately affect children, per the definition of ``covered
regulatory action'' in section 2-202 of the Executive Order. This
action is not a covered regulatory action because it is not
``economically significant'' under Executive Order 12866 and it does
not concern an environmental health risk or safety risk. Although this
action would not establish an environmental standard intended to
mitigate health or safety risks, the information that would be
submitted to EPA in accordance with this rule would be used to inform
the Agency's decision-making process regarding chemical substances to
which children may be disproportionately exposed. This information may
also assist the Agency and others in determining whether the chemical
substances covered in this proposed rule present potential risks, which
would allow the Agency and others to take appropriate action to
investigate and mitigate those risks.
H. Executive Order 13211: Actions Concerning Regulations That
Significantly Affect Energy Supply, Distribution, or Use
This action is not a ``significant energy action'' as defined in
Executive Order 13211 (66 FR 28355, May 22, 2001) because it is not
likely to have a significant adverse effect on the supply,
distribution, or use of energy and has not otherwise been designated by
the Administrator of OMB's Office of Information and Regulatory Affairs
as a ``significant energy action.''
I. National Technology Transfer and Advancement Act (NTTAA)
Because this action does not involve any technical standards, NTTAA
section 12(d), 15 U.S.C. 272 note, does not apply to this action.
J. Executive Order 12898: Federal Actions to Address Environmental
Justice in Minority Populations and Low-Income Populations
This action does not entail special considerations of environmental
justice related issues as delineated by Executive Order 12898 (59 FR
7629, February 16, 1994). However, the Agency believes that the
information collected through this rule will inform the TSCA risk
evaluations that are planned for these chemicals and will thereby
enable the Agency to better protect human health and the environment,
including in low-income and minority communities.
L. Congressional Review Act (CRA)
This action is subject to the CRA (5 U.S.C. 801 et seq.), and EPA
will submit a rule report to each House of the Congress and to the
Comptroller General of the United States. This action is not a ``major
rule'' as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 716
Environmental protection, Chemicals, Hazardous substances, Health
and safety, Reporting and recordkeeping requirements.
Dated: June 17, 2021.
Michal Freedhoff,
Assistant Administrator, Office of Chemical Safety and Pollution
Prevention.
Therefore, for the reasons stated in the preamble, EPA is amending
40 CFR chapter I as follows:
PART 716--HEALTH AND SAFETY DATA REPORTING
0
1. The authority citation for part 716 continues to read as follows:
Authority: 15 U.S.C. 2607(d).
0
2. In Sec. 716.21, add paragraphs (a)(9) and (10) to read as follows:
Sec. 716.21 Chemical specific reporting requirements.
(a) * * *
(9) For 1,3-Butadiene (106-99-0), Butyl benzyl phthalate (BBP)--
1,2-Benzene- dicarboxylic acid, 1- butyl 2(phenylmethyl) ester (85-68-
7), Dibutyl phthalate (DBP) (1,2-Benzene- dicarboxylic acid, 1,2-
dibutyl ester) (84-74-2), o-Dichlorobenzene (95-50-1), p-
Dichlorobenzene (106-46-7), trans-1,2-Dichloroethylene (156-60-5), 1,2-
Dichloropropane (78-87-5), Dicyclohexyl phthalate (84-61-7), Di-
ethylhexyl phthalate (DEHP)--(1,2-Benzene- dicarboxylic acid, 1,2-
bis(2-ethylhexyl) ester) (117-81-7), Di-isobutyl phthalate (DIBP)--
(1,2-Benzene- dicarboxylic acid, 1,2- bis-(2methylpropyl) ester) (84-
69-5), Formaldehyde (50-00-0), 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-
hexamethylcyclopenta [g]-2-benzopyran (HHCB) (1222-05-5), Phthalic
anhydride (85-44-9), 4,4'-(1-Methylethylidene)bis[2, 6-dibromophenol]
(TBBPA) (79-94-7), and 1,1,2-Trichloroethane (79-00-5), all unpublished
studies on health effects (including toxicity studies (in vivo and in
vitro) on carcinogenicity,
[[Page 34153]]
reproductive and developmental effects, genotoxicity, neurotoxicity,
immunotoxicity, endocrine effects, and other systemic toxicity);
toxicokinetics (absorption, distribution, metabolism, or elimination),
including modelling studies, in humans or animals; environmental
effects; environmental fate; physical-chemical properties if performed
as described in 40 CFR 716.50; and occupational (both users and non-
users), general population, consumer, bystander, and environmental
exposure must be submitted. Studies showing any measurable content of
the High-Priority Substance in the tested substance (single substances
or mixture) must be reported. The composition and purity of test
substances must be reported if included as part of the study. Studies
previously submitted to EPA pursuant to a requirement under TSCA or of
the submitter's own accord and studies conducted or to be conducted
pursuant to a TSCA section 4 action are exempt from the submission of
lists of health and safety studies required under 40 CFR 716.35 and the
submission of studies required under this rule.
(10) For purposes of this paragraph, the term organohalogen flame
retardant includes any substances listed in paragraph(d) of this
section under the category ``Organohalogen flame retardants''. For any
organohalogen flame retardant, all unpublished studies on health
effects (including toxicity studies (in vivo and in vitro) on
carcinogenicity, reproductive and developmental effects, genotoxicity,
neurotoxicity, immunotoxicity, endocrine effects, and other systemic
toxicity); toxicokinetics (absorption, distribution, metabolism, or
elimination), including modelling studies, in humans or animals;
environmental fate; physical-chemical properties if performed as
described in 40 CFR 716.50; and occupational (both users and non-
users), general population, consumer, bystander, and environmental
exposure must be submitted. Studies showing any measurable content of
the organohalogen flame retardant in the tested substance (single
substances or mixture) must be reported. The composition and purity of
test substances must be reported if included as part of the study.
Studies previously submitted to EPA pursuant to a requirement under
TSCA or of the submitter's own accord and studies conducted or to be
conducted pursuant to a TSCA section 4 action are exempt from the
submission of lists of health and safety studies requirements under 40
CFR 716.35 and the submission of studies requirements under this rule.
* * * * *
0
3. In Sec. 716.120, amend the table in paragraph (d) by:
0
a. Adding in alphabetical order the category ``High-Priority
Substances'' and entries ``1,3-Butadiene'', ``Butyl benzyl phthalate
(BBP)--1,2-Benzene-dicarboxylic acid, 1-butyl 2(phenylmethyl) ester'',
``Dibutyl phthalate (DBP) (1,2-Benzene-dicarboxylic acid, 1,2-dibutyl
ester)'', ``o-Dichlorobenzene'', ``p-Dichlorobenzene'', ``1,1-
Dichloroethane'', ``1,2-Dichloroethane'', ``Trans-1,2-
Dichloroethylene'', ``1,2-Dichloropropane'', ``Dicyclohexyl
phthalate'', ``Di-ethylhexyl phthalate (DEHP)--(1,2-Benzene-
dicarboxylic acid, 1,2- bis(2-ethylhexyl) ester)'', ``Di-isobutyl
phthalate (DIBP)--(1,2-Benzene- dicarboxylic acid, 1,2- bis-
(2methylpropyl) ester)'', ``Ethylene dibromide'', ``Formaldehyde'',
``1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta [g]-2-
benzopyran (HHCB)'', ``4,4'-(1-Methylethylidene)bis[2, 6-dibromophenol]
(TBBPA)'', ``Phosphoric acid, triphenyl ester (TPP)'', ``Phthalic
anhydride'', ``1,1,2-Trichloroethane'', and ``Tris(2-chloroethyl)
phosphate (TCEP)''; and
0
b. Adding in alphabetical order the category ``Organohalogen flame
retardants'' and entries ``Bis(2-ethylhexyl) tetrabromophthalate'',
``Bis(hexachlorocyclopentadieno)cyclooctane'', ``1,2-Bis(2,4,6-
tribromophenoxy)ethane'', ``1,1'-Ethane-1,2-
diylbis(pentabromobenzene)'', ``2-Ethylhexyl-2,3,4,5-
tetrabromobenzoate'', ``2-(2-Hydroxyethoxy)ethyl 2-hydroxypropyl
3,4,5,6-tetrabromophthalate'', ``2,2'-[(1-Methylethylidene)bis[(2,6-
dibromo-4,1-phenylene)oxymethylene]]bis[oxirane]'', ``Mixture of
chlorinated linear alkanes C14-17 with 45-52% chlorine'', ``N,N-
Ethylene-bis(tetrabromophthalimide)'', ``Pentabromochlorocyclohexane'',
``(Pentabromophenyl)methyl acrylate'', ``Pentabromotoluene'',
``Perbromo-1,4-diphenoxybenzene'', ``Phosphonic acid, (2-chloroethyl)-,
bis(2-chloroethyl) ester'', ``Phosphoric acid, 2,2-bis(chloromethyl)-
1,3-propanediyl tetrakis(2-chloroethyl) ester'', ``Propanoic acid, 2-
bromo-, methyl ester'', ``Tetrabromobisphenol A-bis(2,3-dibromopropyl
ether)'', ``Tetrabromobisphenol A bis(2-hydroxyethyl) ether'',
``Tetrabromobisphenol A diallyl ether'', ``Tetrabromobisphenol A
dimethyl ether'', ``2,4,6-Tribromoaniline'', ``1,3,5-Tribromo-2-(prop-
2-en-1-yloxy)benzene'', ``Tris(2-chloroethyl) phosphite'', ``Tris(1-
chloro-2-propyl)phosphate'', ``Tris(2-chloro-1-propyl)phosphate'',
``Tris(2,3-dibromopropyl) phosphate'', ``1,3,5-Tris(2,3-dibromopropyl)-
1,3,5-triazine-2,4,6(1H,3H,5H)-trione'', ``Tris(1,3-dichloro-2-
propyl)phosphate'', ``Tris(tribromoneopentyl)phosphate'', and ``2,4,6-
Tris-(2,4,6-tribromophenoxy)-1,3,5-triazine''.
The additions read as follows:
Sec. 716.120 Substances and listed mixtures to which this subpart
applies.
* * * * *
(d) * * *
----------------------------------------------------------------------------------------------------------------
Effective
Category CAS No. Special exemptions date Sunset date
----------------------------------------------------------------------------------------------------------------
High-Priority Substances:
1,3-Butadiene............................... 106-99-0 Sec. 716.21(a)(9) 7/29/21 9/27/21
Butyl benzyl phthalate (BBP)--1,2-Benzene- 85-68-7 Sec. 716.21(a)(9) 7/29/21 9/27/21
dicarboxylic acid, 1- butyl 2(phenylmethyl)
ester......................................
Dibutyl phthalate (DBP) (1,2-Benzene- 84-74-2 Sec. 716.21(a)(9) 7/29/21 9/27/21
dicarboxylic acid, 1,2-dibutyl ester)......
o-Dichlorobenzene........................... 95-50-1 Sec. 716.21(a)(9) 7/29/21 9/27/21
p-Dichlorobenzene........................... 106-46-7 Sec. 716.21(a)(9) 7/29/21 9/27/21
1,1-Dichloroethane.......................... 75-34-3 Sec. 716.21(a)(9) 7/29/21 9/27/21
1,2-Dichloroethane.......................... 107-06-2 Sec. 716.21(a)(9) 7/29/21 9/27/21
Trans-1,2-Dichloroethylene.................. 156-60-5 Sec. 716.21(a)(9) 7/29/21 9/27/21
1,2-Dichloropropane......................... 78-87-5 Sec. 716.21(a)(9) 7/29/21 9/27/21
Dicyclohexyl phthalate...................... 84-61-7 Sec. 716.21(a)(9) 7/29/21 9/27/21
Di-ethylhexyl phthalate (DEHP)--(1,2-Benzene- 117-81-7 Sec. 716.21(a)(9) 7/29/21 9/27/21
dicarboxylic acid, 1,2- bis(2-ethylhexyl)
ester).....................................
[[Page 34154]]
Di-isobutyl phthalate (DIBP)--(1,2-Benzene- 84-69-5 Sec. 716.21(a)(9) 7/29/21 9/27/21
dicarboxylic acid, 1,2- bis-(2methylpropyl)
ester).....................................
Ethylene dibromide.......................... 106-93-4 Sec. 716.21(a)(9) 7/29/21 9/27/21
Formaldehyde................................ 50-00-0 Sec. 716.21(a)(9) 7/29/21 9/27/21
1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8- 1222-05-5 Sec. 716.21(a)(9) 7/29/21 9/27/21
hexamethylcyclopenta [g]-2-benzopyran
(HHCB).....................................
4,4'-(1-Methylethylidene)bis[2, 6- 79-94-7 Sec. 716.21(a)(9) 7/29/21 9/27/21
dibromophenol] (TBBPA).....................
Phosphoric acid, triphenyl ester (TPP)...... 115-86-6 Sec. 716.21(a)(9) 7/29/21 9/27/21
Phthalic anhydride.......................... 85-44-9 Sec. 716.21(a)(9) 7/29/21 9/27/21
1,1,2-Trichloroethane....................... 79-00-5 Sec. 716.21(a)(9) 7/29/21 9/27/21
Tris(2-chloroethyl) phosphate (TCEP)........ 115-96-8 Sec. 716.21(a)(9) 7/29/21 9/27/21
* * * * * * *
Organohalogen flame retardants:
Bis(2-ethylhexyl) tetrabromophthalate....... 26040-51-7 Sec. 716.21(a)(10) 7/29/21 9/27/21
Bis(hexachlorocyclopentadieno)cyclooctane... 13560-89-9 Sec. 716.21(a)(10) 7/29/21 9/27/21
1,2-Bis(2,4,6-tribromophenoxy)ethane........ 37853-59-1 Sec. 716.21(a)(10) 7/29/21 9/27/21
1,1'-Ethane-1,2-diylbis(pentabromobenzene).. 84852-53-9 Sec. 716.21(a)(10) 7/29/21 9/27/21
2-Ethylhexyl-2,3,4,5-tetrabromobenzoate..... 183658-27-7 Sec. 716.21(a)(10) 7/29/21 9/27/21
2-(2-Hydroxyethoxy)ethyl 2-hydroxypropyl 20566-35-2 Sec. 716.21(a)(10) 7/29/21 9/27/21
3,4,5,6-tetrabromophthalate................
2,2'-[(1-Methylethylidene)bis[(2,6-dibromo- 3072-84-2 Sec. 716.21(a)(10) 7/29/21 9/27/21
4,1-phenylene)oxymethylene]]bis[oxirane]...
Mixture of chlorinated linear alkanes C14-17 85535-85-9 Sec. 716.21(a)(10) 7/29/21 9/27/21
with 45-52% chlorine.......................
N,N-Ethylene-bis(tetrabromophthalimide)..... 32588-76-4 Sec. 716.21(a)(10) 7/29/21 9/27/21
Pentabromochlorocyclohexane................. 87-84-3 Sec. 716.21(a)(10) 7/29/21 9/27/21
(Pentabromophenyl)methyl acrylate........... 59447-55-1 Sec. 716.21(a)(10) 7/29/21 9/27/21
Pentabromotoluene........................... 87-83-2 Sec. 716.21(a)(10) 7/29/21 9/27/21
Perbromo-1,4-diphenoxybenzene............... 58965-66-5 Sec. 716.21(a)(10) 7/29/21 9/27/21
Phosphonic acid, (2-chloroethyl)-, bis(2- 6294-34-4 Sec. 716.21(a)(10) 7/29/21 9/27/21
chloroethyl) ester.........................
Phosphoric acid, 2,2-bis(chloromethyl)-1,3- 38051-10-4 Sec. 716.21(a)(10) 7/29/21 9/27/21
propanediyl tetrakis(2-chloroethyl) ester..
Propanoic acid, 2-bromo-, methyl ester...... 5445-17-0 Sec. 716.21(a)(10) 7/29/21 9/27/21
Tetrabromobisphenol A-bis(2,3-dibromopropyl 21850-44-2 Sec. 716.21(a)(10) 7/29/21 9/27/21
ether).....................................
Tetrabromobisphenol A bis(2-hydroxyethyl) 4162-45-2 Sec. 716.21(a)(10) 7/29/21 9/27/21
ether......................................
Tetrabromobisphenol A diallyl ether......... 25327-89-3 Sec. 716.21(a)(10) 7/29/21 9/27/21
Tetrabromobisphenol A dimethyl ether........ 37853-61-5 Sec. 716.21(a)(10) 7/29/21 9/27/21
2,4,6-Tribromoaniline....................... 147-82-0 Sec. 716.21(a)(10) 7/29/21 9/27/21
1,3,5-Tribromo-2-(prop-2-en-1-yloxy)benzene. 3278-89-5 Sec. 716.21(a)(10) 7/29/21 9/27/21
Tris(2-chloroethyl)phosphite................ 140-08-9 Sec. 716.21(a)(10) 7/29/21 9/27/21
Tris(1-chloro-2-propyl)phosphate............ 13674-84-5 Sec. 716.21(a)(10) 7/29/21 9/27/21
Tris(2-chloro-1-propyl)phosphate............ 6145-73-9 Sec. 716.21(a)(10) 7/29/21 9/27/21
Tris(2,3-dibromopropyl)phosphate............ 126-72-7 Sec. 716.21(a)(10) 7/29/21 9/27/21
1,3,5-Tris(2,3-dibromopropyl)-1,3,5-triazine- 52434-90-9 Sec. 716.21(a)(10) 7/29/21 9/27/21
2,4,6(1H,3H,5H)-trione.....................
Tris(1,3-dichloro-2-propyl)phosphate........ 13674-87-8 Sec. 716.21(a)(10) 7/29/21 9/27/21
Tris(tribromoneopentyl)phosphate............ 19186-97-1 Sec. 716.21(a)(10) 7/29/21 9/27/21
2,4,6-Tris-(2,4,6-tribromophenoxy)-1,3,5- 25713-60-4 Sec. 716.21(a)(10) 7/29/21 9/27/21
triazine...................................
----------------------------------------------------------------------------------------------------------------
[FR Doc. 2021-13212 Filed 6-28-21; 8:45 am]
BILLING CODE 6560-50-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 29, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.